Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process

Highlights • Specific aspects of information from next-generation sequencing. • Value of incidental results from next-generation sequencing. • Importance of incidental result in the informed consent procedure. • Pilot investigation to inform the consent process in rare disease.

Saved in:
Bibliographic Details
Published in:Public health (London) 2016-09, Vol.138, p.157-159
Main Authors: Pélissier, A, Peyron, C, Béjean, S
Format: Article
Language:English
Subjects:
Economics and Finance
Focus Groups
High-Throughput Nucleotide Sequencing
Humanities and Social Sciences
Humans
Incidental Findings
Infectious Disease
Informed Consent
Internal Medicine
Patient Preference
Pilot Projects
Rare Diseases - diagnosis
Rare Diseases - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743
cites cdi_FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743
container_end_page 159
container_issue
container_start_page 157
container_title Public health (London)
container_volume 138
creator Pélissier, A
Peyron, C
Béjean, S
description Highlights • Specific aspects of information from next-generation sequencing. • Value of incidental results from next-generation sequencing. • Importance of incidental result in the informed consent procedure. • Pilot investigation to inform the consent process in rare disease.
doi_str_mv 10.1016/j.puhe.2016.03.011
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01549997v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0033350616001025</els_id><sourcerecordid>1817050533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743</originalsourceid><addsrcrecordid>eNp9Uk1v1DAQtRCIbgt_gAPKDTgkzMQfSRBCqqpCkVZwAM6W4510vWTtxU4q-u9x2LYHDsgHW573nj3vDWMvECoEVG931WHeUlXncwW8AsRHbIWiUaVUqB6zFQDnJZegTthpSjsAqBsun7KTukGsedOuWPhCv6fymjxFM7ngi0S_ZvLW-evC-cKOzjtrxuIQjZ2cpXfFEMO-mLZUHDKB_JRe5SINFDOLUjGFv0XnhxD3tCls8CmjMibkcnrGngxmTPT8bj9jPz5efr-4KtdfP32-OF-XVgg5ldZIw1tsuZGtVYZ6CwPUNAxWCQE9wAZ7MQjL-75Rdd91Spm8qB0E500j-Bl7c9TdmlEfotubeKuDcfrqfK2XO0Apuq5rbjBjXx-x-Y-5-TTpvUuWxtF4CnPS2GIDEiTnGVofoTaGlHLbD9oIeglF7_QSil5C0cDzM4v-yzv9uc-WPFDuU8iA90cAZUduHEWdrFvs3LhIdtKb4P6v_-Ef-n1sP-mW0i7M0WevNepUa9DflrFYpgIVAEIt-R8nXLND</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1817050533</pqid></control><display><type>article</type><title>Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process</title><source>ScienceDirect Journals</source><creator>Pélissier, A ; Peyron, C ; Béjean, S</creator><creatorcontrib>Pélissier, A ; Peyron, C ; Béjean, S</creatorcontrib><description>Highlights • Specific aspects of information from next-generation sequencing. • Value of incidental results from next-generation sequencing. • Importance of incidental result in the informed consent procedure. • Pilot investigation to inform the consent process in rare disease.</description><identifier>ISSN: 0033-3506</identifier><identifier>EISSN: 1476-5616</identifier><identifier>DOI: 10.1016/j.puhe.2016.03.011</identifier><identifier>PMID: 27112378</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Economics and Finance ; Focus Groups ; High-Throughput Nucleotide Sequencing ; Humanities and Social Sciences ; Humans ; Incidental Findings ; Infectious Disease ; Informed Consent ; Internal Medicine ; Patient Preference ; Pilot Projects ; Rare Diseases - diagnosis ; Rare Diseases - genetics</subject><ispartof>Public health (London), 2016-09, Vol.138, p.157-159</ispartof><rights>The Royal Society for Public Health</rights><rights>2016 The Royal Society for Public Health</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743</citedby><cites>FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743</cites><orcidid>0000-0002-1042-0039 ; 0000-0003-3823-0859 ; 0000-0003-2875-9257</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27112378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://u-bourgogne.hal.science/hal-01549997$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pélissier, A</creatorcontrib><creatorcontrib>Peyron, C</creatorcontrib><creatorcontrib>Béjean, S</creatorcontrib><title>Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process</title><title>Public health (London)</title><addtitle>Public Health</addtitle><description>Highlights • Specific aspects of information from next-generation sequencing. • Value of incidental results from next-generation sequencing. • Importance of incidental result in the informed consent procedure. • Pilot investigation to inform the consent process in rare disease.</description><subject>Economics and Finance</subject><subject>Focus Groups</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Incidental Findings</subject><subject>Infectious Disease</subject><subject>Informed Consent</subject><subject>Internal Medicine</subject><subject>Patient Preference</subject><subject>Pilot Projects</subject><subject>Rare Diseases - diagnosis</subject><subject>Rare Diseases - genetics</subject><issn>0033-3506</issn><issn>1476-5616</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9Uk1v1DAQtRCIbgt_gAPKDTgkzMQfSRBCqqpCkVZwAM6W4510vWTtxU4q-u9x2LYHDsgHW573nj3vDWMvECoEVG931WHeUlXncwW8AsRHbIWiUaVUqB6zFQDnJZegTthpSjsAqBsun7KTukGsedOuWPhCv6fymjxFM7ngi0S_ZvLW-evC-cKOzjtrxuIQjZ2cpXfFEMO-mLZUHDKB_JRe5SINFDOLUjGFv0XnhxD3tCls8CmjMibkcnrGngxmTPT8bj9jPz5efr-4KtdfP32-OF-XVgg5ldZIw1tsuZGtVYZ6CwPUNAxWCQE9wAZ7MQjL-75Rdd91Spm8qB0E500j-Bl7c9TdmlEfotubeKuDcfrqfK2XO0Apuq5rbjBjXx-x-Y-5-TTpvUuWxtF4CnPS2GIDEiTnGVofoTaGlHLbD9oIeglF7_QSil5C0cDzM4v-yzv9uc-WPFDuU8iA90cAZUduHEWdrFvs3LhIdtKb4P6v_-Ef-n1sP-mW0i7M0WevNepUa9DflrFYpgIVAEIt-R8nXLND</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Pélissier, A</creator><creator>Peyron, C</creator><creator>Béjean, S</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>BXJBU</scope><orcidid>https://orcid.org/0000-0002-1042-0039</orcidid><orcidid>https://orcid.org/0000-0003-3823-0859</orcidid><orcidid>https://orcid.org/0000-0003-2875-9257</orcidid></search><sort><creationdate>20160901</creationdate><title>Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process</title><author>Pélissier, A ; Peyron, C ; Béjean, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Economics and Finance</topic><topic>Focus Groups</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Incidental Findings</topic><topic>Infectious Disease</topic><topic>Informed Consent</topic><topic>Internal Medicine</topic><topic>Patient Preference</topic><topic>Pilot Projects</topic><topic>Rare Diseases - diagnosis</topic><topic>Rare Diseases - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pélissier, A</creatorcontrib><creatorcontrib>Peyron, C</creatorcontrib><creatorcontrib>Béjean, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société</collection><jtitle>Public health (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pélissier, A</au><au>Peyron, C</au><au>Béjean, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process</atitle><jtitle>Public health (London)</jtitle><addtitle>Public Health</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>138</volume><spage>157</spage><epage>159</epage><pages>157-159</pages><issn>0033-3506</issn><eissn>1476-5616</eissn><abstract>Highlights • Specific aspects of information from next-generation sequencing. • Value of incidental results from next-generation sequencing. • Importance of incidental result in the informed consent procedure. • Pilot investigation to inform the consent process in rare disease.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>27112378</pmid><doi>10.1016/j.puhe.2016.03.011</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-1042-0039</orcidid><orcidid>https://orcid.org/0000-0003-3823-0859</orcidid><orcidid>https://orcid.org/0000-0003-2875-9257</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0033-3506
ispartof Public health (London), 2016-09, Vol.138, p.157-159
issn 0033-3506
1476-5616
language eng
recordid cdi_hal_primary_oai_HAL_hal_01549997v1
source ScienceDirect Journals
subjects Economics and Finance
Focus Groups
High-Throughput Nucleotide Sequencing
Humanities and Social Sciences
Humans
Incidental Findings
Infectious Disease
Informed Consent
Internal Medicine
Patient Preference
Pilot Projects
Rare Diseases - diagnosis
Rare Diseases - genetics
title Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A58%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Next-generation%20sequencing%20in%20clinical%20practice:%20from%20the%20patients'%20preferences%20to%20the%20informed%20consent%20process&rft.jtitle=Public%20health%20(London)&rft.au=P%C3%A9lissier,%20A&rft.date=2016-09-01&rft.volume=138&rft.spage=157&rft.epage=159&rft.pages=157-159&rft.issn=0033-3506&rft.eissn=1476-5616&rft_id=info:doi/10.1016/j.puhe.2016.03.011&rft_dat=%3Cproquest_hal_p%3E1817050533%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-ca5a38183a58c6aebc0f02effc6440b00d1b4f4c3bb762b9966a6a6e8f4337743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1817050533&rft_id=info:pmid/27112378&rfr_iscdi=true